rs148781346
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004006.3(DMD):c.4093C>T(p.Leu1365Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,208,913 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 35 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004006.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMD | NM_004006.3 | c.4093C>T | p.Leu1365Phe | missense_variant | 30/79 | ENST00000357033.9 | NP_003997.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMD | ENST00000357033.9 | c.4093C>T | p.Leu1365Phe | missense_variant | 30/79 | 1 | NM_004006.3 | ENSP00000354923 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000629 AC: 70AN: 111222Hom.: 0 Cov.: 23 AF XY: 0.000359 AC XY: 12AN XY: 33430
GnomAD3 exomes AF: 0.000181 AC: 33AN: 182632Hom.: 0 AF XY: 0.0000594 AC XY: 4AN XY: 67352
GnomAD4 exome AF: 0.0000720 AC: 79AN: 1097640Hom.: 0 Cov.: 30 AF XY: 0.0000633 AC XY: 23AN XY: 363134
GnomAD4 genome AF: 0.000629 AC: 70AN: 111273Hom.: 0 Cov.: 23 AF XY: 0.000358 AC XY: 12AN XY: 33491
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 13, 2016 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 22, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Leu1365Phe va riant in DMD has not been previously reported in individuals with muscular dystr ophy, but has been identified in 0.19% (35/18082) of African chromosomes by the genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs 148781346). This variant has been reported in ClinVar (Variation ID: 94611). Ple ase note that for diseases with clinical variability, reduced penetrance, or rec essive inheritance, pathogenic variants may be present at a low frequency in the general population. Computational prediction tools and conservation analysis su ggest that the p.Leu1365Phe variant may impact the protein, though this informat ion is not predictive enough to determine pathogenicity. In summary, while the c linical significance of the p.Leu1365Phe variant is uncertain, its frequency sug gests that it is more likely to be benign. - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 06, 2023 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 17, 2021 | - - |
DMD-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 30, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Duchenne muscular dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at